Martin Riediker
Directeur/Membre du Conseil chez Diality, Inc.
Profil
Martin Riediker is currently a Director at Diality, Inc., Perseo pharma AG, and INOFEA AG.
He was formerly the Chairman at Plaxica Ltd.
and Micro-Macinazione SA, Lead Director at Polymetrix AG, and Chief Technology & Innovation Officer at Ciba Corp.
He also served as an Advisor at Pangaea Ventures Ltd.
Dr. Riediker holds a doctorate degree from Princeton University.
Postes actifs de Martin Riediker
| Sociétés | Poste | Début |
|---|---|---|
Diality, Inc.
 Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Directeur/Membre du Conseil | 01/03/2018 |
INOFEA AG
 INOFEA AG Packaged SoftwareTechnology Services INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018. | Directeur/Membre du Conseil | - |
Perseo pharma AG
 Perseo pharma AG BiotechnologyHealth Technology Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019. | Directeur/Membre du Conseil | 01/03/2019 |
Anciens postes connus de Martin Riediker
| Sociétés | Poste | Fin |
|---|---|---|
Pangaea Ventures Ltd.
 Pangaea Ventures Ltd. Investment ManagersFinance Pangaea Ventures Ltd(Pangaea Ventures) is a venture capital firm founded in 2000 by Chris Erickson. The firm is headquartered in Vancouver, British Columbia, Canada. | Private Equity Investor | 31/08/2009 |
Ciba Corp.
 Ciba Corp. Miscellaneous Commercial ServicesCommercial Services Ciba Corp. manufactured chemical products. It is engaged in producing plastic additives, coatings, water and paper treatments, textile effects, hom, and personal products. The firm ingredients are used in a variety of products, including inks, dyes, pigments, antimicrobials, paints, polymers and electronic materials. The company was founded in 1996 and was headquartered in High Point, NC. | Directeur Technique/Scientifique/R&D | 01/01/2009 |
Polymetrix AG
 Polymetrix AG Electric UtilitiesUtilities Polymetrix AG designs, supplies, and installs industrial plants for the thermal treatment of bulk materials primarily for producing virgin and recycled polyesters, polyamides (PA), and other polymers worldwide. The firm builds various plants in the fields of PET recycling, polyamide conditioning, solid state polycondensation (SSP), and polybutylene terephthalate (PBT). It also provides consulting services in the fields of process optimization and extension or conversion of existing plants, engineering and EPCm services, such as project management, proprietary equipment design, basic und detail engineering, automation, procurement and logistics and quality assurance and checks and construction management and services and testing programs, which include consulting for food approvals, material evaluation and testing, process simulation, plant retrofit services, continuous pilot plant testing and on-site support. The company was founded in 2012 and is headquartered in Oberburen, Switzerland. | Directeur/Membre du Conseil | - |
Plaxica Ltd.
 Plaxica Ltd. Chemicals: Major DiversifiedProcess Industries Plaxica Ltd. develops a new generation of polymers derived from sustainable resources. The firm's technology allows polylactic acid to replace traditional polymers produced from oil. The company was founded by John Edward Hamlin, Edward Leslie Marshall and Vernon C. Gibson in 2008 and is headquartered in Redcar, the United Kingdom. | Président | - |
Micro-Macinazione SA
 Micro-Macinazione SA Pharmaceuticals: MajorHealth Technology Micro-Macinazione SA provides micronization technologies and services for the pharmaceutical and fine chemical industry. The firm offers services for the micronization of bulk active pharmaceutical ingredients and also designs and produces jet spiral jet mills, isolated jet mills, cosmetic jet mills, isolators, feeders, cryogenic exchangers and ancillary equipment which are used in the micronization process. The company was founded in 1970 and is headquartered in Molinazzo di Monteggio, Switzerland. | Président | - |
Formation de Martin Riediker
| Princeton University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Pangaea Ventures Ltd.
Pangaea Ventures Ltd. Investment ManagersFinance Pangaea Ventures Ltd(Pangaea Ventures) is a venture capital firm founded in 2000 by Chris Erickson. The firm is headquartered in Vancouver, British Columbia, Canada. | Finance |
Micro-Macinazione SA
Micro-Macinazione SA Pharmaceuticals: MajorHealth Technology Micro-Macinazione SA provides micronization technologies and services for the pharmaceutical and fine chemical industry. The firm offers services for the micronization of bulk active pharmaceutical ingredients and also designs and produces jet spiral jet mills, isolated jet mills, cosmetic jet mills, isolators, feeders, cryogenic exchangers and ancillary equipment which are used in the micronization process. The company was founded in 1970 and is headquartered in Molinazzo di Monteggio, Switzerland. | Health Technology |
Plaxica Ltd.
Plaxica Ltd. Chemicals: Major DiversifiedProcess Industries Plaxica Ltd. develops a new generation of polymers derived from sustainable resources. The firm's technology allows polylactic acid to replace traditional polymers produced from oil. The company was founded by John Edward Hamlin, Edward Leslie Marshall and Vernon C. Gibson in 2008 and is headquartered in Redcar, the United Kingdom. | Process Industries |
Ciba Corp.
Ciba Corp. Miscellaneous Commercial ServicesCommercial Services Ciba Corp. manufactured chemical products. It is engaged in producing plastic additives, coatings, water and paper treatments, textile effects, hom, and personal products. The firm ingredients are used in a variety of products, including inks, dyes, pigments, antimicrobials, paints, polymers and electronic materials. The company was founded in 1996 and was headquartered in High Point, NC. | Commercial Services |
Polymetrix AG
Polymetrix AG Electric UtilitiesUtilities Polymetrix AG designs, supplies, and installs industrial plants for the thermal treatment of bulk materials primarily for producing virgin and recycled polyesters, polyamides (PA), and other polymers worldwide. The firm builds various plants in the fields of PET recycling, polyamide conditioning, solid state polycondensation (SSP), and polybutylene terephthalate (PBT). It also provides consulting services in the fields of process optimization and extension or conversion of existing plants, engineering and EPCm services, such as project management, proprietary equipment design, basic und detail engineering, automation, procurement and logistics and quality assurance and checks and construction management and services and testing programs, which include consulting for food approvals, material evaluation and testing, process simulation, plant retrofit services, continuous pilot plant testing and on-site support. The company was founded in 2012 and is headquartered in Oberburen, Switzerland. | Utilities |
Diality, Inc.
Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Health Technology |
INOFEA AG
INOFEA AG Packaged SoftwareTechnology Services INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018. | Technology Services |
Perseo pharma AG
Perseo pharma AG BiotechnologyHealth Technology Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019. | Health Technology |
